The zoonosis human monkeypox (MPX) was discovered in 1970, twelve years after the discovery of monkeypox virus (MPXV) in a Danish laboratory in 1958. Historically confined to West Africa (WA) and the Congo basin (CB), new epidemics in Sudan and the United States of America (USA) have fuelled new research highlighting environmental factors contributing to the expanded geographical spread of monkeypox virus (MPXV). A systematic literature review was conducted in MEDLINE^® (Ovid), MEDLINE^® (PubMed) and Google Scholar databases using the search terms: monkeypox, MPXV and “human monkeypox”. The literature revealed MPX has classic prodromal symptoms followed by a total body rash. The sole distinguishing clinical characteristic from other pox-like illnesses is the profound lymphadenopathy. Laboratory diagnosis of MPX is essential, a suitable test for endemic areas is under development but not yet available. For the time being anti-poxvirus antibodies in an unvaccinated individual with a history of severe illness and rash can suggest MPX infection. The reservoir host remains elusive yet the rope squirrel and Gambian pouched rat appear to be the most likely candidates. Transmission includes fomite, droplet, direct contact with infected humans or animals and consumption of infected meat. Though smallpox vaccination is protective against MPXV, new non-immune generations contribute to increasing incidence. Environmental factors are increasing the frequency of contact with potential hosts, thus increasing the risk of animal-to-human transmission. Increased risk of transmission through globalisation, conflict and environmental influences makes MPX a more realistic threat to previously unaffected countries. Health worker training and further development and accessibility of suitable diagnostic tests, vaccinations and anti-viral treatment is becoming increasingly necessary.

Despite numerous technical advances in recent years, many occupational health problems still persist in modern dentistry. These include percutaneous exposure incidents (PEI); exposure to infectious diseases (including bioaerosols), radiation, dental materials, and noise; musculoskeletal disorders; dermatitis and respiratory disorders; eye injuries; and psychological problems. PEI remain a particular concern, as there is an almost constant risk of exposure to serious infectious agents. Strategies to minimise PEI and their consequences should continue to be employed, including sound infection control practices, continuing education and hepatitis B immunisation. As part of any infection control protocols, dentists should continue to utilise personal protective measures and appropriate sterilisation or other high-level disinfection techniques. Aside from biological hazards, dentists continue to suffer a high prevalence of musculoskeletal disorders (MSD), especially of the back, neck and shoulders. To fully understand the nature of these problems, further studies are needed to identify causative factors and other correlates of MSD. Continuing education and investigation of appropriate interventions to help reduce the prevalence of MSD and contact dermatitis are also needed. For these reasons, it is therefore important that dentists remain constantly informed regarding up-to-date measures on how to deal with newer technologies and dental materials.

Tobacco smoking by physicians represents a contentious issue in public health, and regardless of what country it originates from, the need for accurate, historical data is paramount. As such, this article provides an international comparison of all modern literature describing the tobacco smoking habits of contemporary physicians.

Background: Musculoskeletal disorders (MSD) represent an important occupational health issue in dentistry. Given the significance of this topic, we considered it necessary to investigate the prevalence and impact of MSD among Australian dentists.Methods: In 2004, a self‐reporting questionnaire was mailed to a random sample of 400 dentists registered with the Queensland Branch of the Australian Dental Association.Results: A total of 285 questionnaires (73.1 per cent) were completed and returned. Of the respondents, 73.3 per cent were male and 26.7 per cent female, with a mean age of 45.2 years (SD = 11.9 years). Most were general dentists (89.1 per cent), with the remainder being specialists (10.9 per cent). Most dentists (87.2 per cent) reported having experienced at least one MSD symptom in the past 12 months. The most prevalent MSD during the previous 12 months were reported at the neck (57.5 per cent), lower back (53.7 per cent) and shoulder (53.3 per cent). MSD which interfered with daily activities during the previous 12 months were reported at the neck (24.6 per cent), the lower back (22.1 per cent) and the shoulders (21.8 per cent). Over one‐third (37.5 per cent) of dentists had sought medical advice or treatment for an MSD during the previous 12‐month period. Almost 1 in 10 dentists (9.1 per cent) reported taking leave in the previous 12 months because of an MSD. Among those who took sick leave for an MSD, the mean time taken was 11.5 days (SD=16.0 days).Conclusions: Overall, this study suggests that MSD represents a major occupational health issue for Queensland dentists, the occurrence of which is similar to reports from other countries. MSD was shown to interfere with daily activities in some cases, while a considerable proportion of dentists had also sought medical attention for their symptoms. Further research is now needed to more carefully elucidate the impact of MSD in this particular occupational group, especially in relation to cessation or reduction of clinical practice, and also to help identify specific risk factors and effective measures for reducing MSD among dentists in Queensland and elsewhere.